Source:http://linkedlifedata.com/resource/pubmed/id/20037298
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2009-12-28
|
pubmed:abstractText |
PURPOSE: To assess current trends and problems in chemotherapy for elderly patients with unresectable gastric cancer. PATIENTS AND METHODS: Patients with unresectable gastric cancer were divided into two groups: an elderly group aged 70 years or older (n=28), and a control group aged younger than 70 years (n=46). The feasibility, safety, and efficacy of chemotherapy were compared between the two groups. The induction rate for a first-line treatment did not differ between the groups (89% for the elderly group versus 93% for the control group). A regimen comprising S-1 and cisplatinum (CDDP) was selected most frequently as the first-line treatment in both groups. When an analysis was restricted to patients given S-1 and CDDP, the elderly group showed fewer cycles of CDDP administration, a higher rate of grade 3 or worse adverse events, a lower rate of switching to a second-line treatment, and a shorter overall survival than the control group, although the p values did not reach a significant level. Among patients aged 70 years or more, those given S-1 alone showed an overall survival equivalent to that for patients given S-1 and CDDP. In conclusion, in clinical practice, it seems appropriate to consider whether the S-1+CDDP regimen is the most optimal first-line treatment for elderly patients with gastric cancer.
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations,
http://linkedlifedata.com/resource/pubmed/chemical/Oxonic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/S 1 (combination),
http://linkedlifedata.com/resource/pubmed/chemical/Tegafur
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0385-0684
|
pubmed:author |
pubmed-author:HokamaNaokoN,
pubmed-author:IshibashiKeiichirouK,
pubmed-author:IshidaHideyukiH,
pubmed-author:IshiguroToruT,
pubmed-author:KubotaShouS,
pubmed-author:MiyazakiTatsuyaT,
pubmed-author:OkadaNorimichiN,
pubmed-author:SakimotoTakehikoT,
pubmed-author:YamadaHirofumiH,
pubmed-author:YokoyamaMasaruM,
pubmed-author:YokoyamaYouzouY
|
pubmed:issnType |
Print
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1982-4
|
pubmed:meshHeading |
pubmed-meshheading:20037298-Adult,
pubmed-meshheading:20037298-Age Factors,
pubmed-meshheading:20037298-Aged,
pubmed-meshheading:20037298-Cisplatin,
pubmed-meshheading:20037298-Drug Combinations,
pubmed-meshheading:20037298-Female,
pubmed-meshheading:20037298-Humans,
pubmed-meshheading:20037298-Male,
pubmed-meshheading:20037298-Middle Aged,
pubmed-meshheading:20037298-Oxonic Acid,
pubmed-meshheading:20037298-Retrospective Studies,
pubmed-meshheading:20037298-Stomach Neoplasms,
pubmed-meshheading:20037298-Tegafur
|
pubmed:year |
2009
|
pubmed:articleTitle |
[Current trends and problems in chemotherapy for elderly patients with advanced gastric cancer].
|
pubmed:affiliation |
Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
English Abstract
|